Behera S, Mishra D, Mahajan B, Mantan M, Bansal S
J Epilepsy Res. 2024; 14(2):73-80.
PMID: 39720196
PMC: 11664055.
DOI: 10.14581/jer.24013.
Avhad T, Dakhode S
J Orthop Case Rep. 2024; 14(7):41-45.
PMID: 39035372
PMC: 11258749.
DOI: 10.13107/jocr.2024.v14.i07.4568.
Likasitthananon N, Nabangchang C, Simasathien T, Vichutavate S, Phatarakijnirund V, Suwanpakdee P
BMC Pediatr. 2021; 21(1):432.
PMID: 34600517
PMC: 8487104.
DOI: 10.1186/s12887-021-02906-7.
Diemar S, Jorgensen N, Eiken P, Suetta C, Andersen N, Sejling A
Contemp Clin Trials Commun. 2020; 19:100587.
PMID: 32566796
PMC: 7298402.
DOI: 10.1016/j.conctc.2020.100587.
Fan H, Wang S, Peng Y, Lee H
Int J Environ Res Public Health. 2020; 17(10).
PMID: 32456093
PMC: 7277424.
DOI: 10.3390/ijerph17103675.
Vitamin D Status in Epileptic Children on Valproic Acid; a Case-Control Study.
Abdullah A, Mousheer Z
Arch Acad Emerg Med. 2020; 8(1):e13.
PMID: 32259112
PMC: 7130439.
Adherence to risk management guidelines for drugs which cause vitamin D deficiency - big data from the Swedish health system.
Nordqvist O, Lonnbom Svensson U, Brudin L, Wanby P, Carlsson M
Drug Healthc Patient Saf. 2019; 11:19-28.
PMID: 30962725
PMC: 6432880.
DOI: 10.2147/DHPS.S188187.
Vitamin D in epilepsy: vitamin D levels in epilepsy patients, patients on antiepileptic drug polytherapy and drug-resistant epilepsy sufferers.
Nagarjunakonda S, Amalakanti S, Uppala V, Rajanala L, Athina S
Eur J Clin Nutr. 2015; 70(1):140-2.
PMID: 26220571
DOI: 10.1038/ejcn.2015.127.
Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis.
Zhang Y, Zheng Y, Zhu J, Zhang J, Zheng Z
J Zhejiang Univ Sci B. 2015; 16(7):611-21.
PMID: 26160719
PMC: 4506952.
DOI: 10.1631/jzus.B1500021.
Osteomalacia: a forgotten cause of fractures in the elderly.
Rokan Z, Kealey W
BMJ Case Rep. 2015; 2015.
PMID: 25666245
PMC: 4330413.
DOI: 10.1136/bcr-2014-207184.
Bone mineral density in ambulatory children with epilepsy.
Yaghini O, Tonekaboni S, Amir Shahkarami S, Ahmad Abadi F, Shariat F, Abdollah Gorji F
Indian J Pediatr. 2014; 82(3):225-9.
PMID: 25106841
DOI: 10.1007/s12098-014-1518-0.
Influence of drugs on vitamin D and calcium metabolism.
Grober U, Kisters K
Dermatoendocrinol. 2012; 4(2):158-66.
PMID: 22928072
PMC: 3427195.
DOI: 10.4161/derm.20731.
May long term oxcarbazepine treatment be lead to secondary hyperparathyroidism?.
Babacan O, Karaoglu A, Vurucu S, Yesilkaya E, Yesilyurt O, Cayci T
J Clin Neurol. 2012; 8(1):65-8.
PMID: 22523515
PMC: 3325434.
DOI: 10.3988/jcn.2012.8.1.65.
The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.
Richens A
Br J Clin Pharmacol. 2012; 1(3):185-7.
PMID: 22454944
PMC: 1402547.
DOI: 10.1111/j.1365-2125.1974.tb00233.x.
Nuclear receptor PXR, transcriptional circuits and metabolic relevance.
Ihunnah C, Jiang M, Xie W
Biochim Biophys Acta. 2011; 1812(8):956-63.
PMID: 21295138
PMC: 3111845.
DOI: 10.1016/j.bbadis.2011.01.014.
Diseases affecting bone quality: beyond osteoporosis.
Unnanuntana A, Rebolledo B, Khair M, DiCarlo E, Lane J
Clin Orthop Relat Res. 2010; 469(8):2194-206.
PMID: 21107923
PMC: 3126973.
DOI: 10.1007/s11999-010-1694-9.
A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.
Lee R, Lyles K, Colon-Emeric C
Am J Geriatr Pharmacother. 2010; 8(1):34-46.
PMID: 20226391
PMC: 3570810.
DOI: 10.1016/j.amjopharm.2010.02.003.
Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy.
Nettekoven S, Strohle A, Trunz B, Wolters M, Hoffmann S, Horn R
Eur J Pediatr. 2008; 167(12):1369-77.
PMID: 18270736
DOI: 10.1007/s00431-008-0672-7.
Maintaining strong bones: strong opinions, little evidence.
Bergen D
Epilepsy Curr. 2007; 7(5):123-4.
PMID: 17998969
PMC: 2043138.
DOI: 10.1111/j.1535-7511.2007.00195.x.
Antiepileptic drugs and bone metabolism.
Valsamis H, Arora S, Labban B, McFarlane S
Nutr Metab (Lond). 2006; 3:36.
PMID: 16956398
PMC: 1586194.
DOI: 10.1186/1743-7075-3-36.
